Total Non-Current Liabilities

$727.36K

Quarterly · Period ending: Jun 30, 2026 · USD

Latest reported$727.36Kperiod endingJun 30, 2026

APRE Quarterly Total Non-Current Liabilities ($112.59M → $727.36K)

Quarterly total non-current liabilities

High-resolution chart · PNG

APRE total non-current liabilities history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Aprea Therapeutics, Inc. Total Non-Current Liabilities — Quarterly (USD)
Period ending	Total Non-Current Liabilities (USD)
Jun 30, 2026	727,361
Mar 31, 2026	0
Dec 31, 2025	727,361
Sep 30, 2025	0
Jun 30, 2025	727,361
Mar 31, 2025	1,311,063
Dec 31, 2024	1,311,063
Sep 30, 2024	1,311,063
Jun 30, 2024	1,311,063
Mar 31, 2024	1,311,063
Dec 31, 2023	1,311,063
Sep 30, 2023	1,311,063
Jun 30, 2023	1,311,063
Mar 31, 2023	1,311,063
Dec 31, 2022	1,311,063
Sep 30, 2022	2,998,537
Jun 30, 2022	68,777,468
Mar 31, 2022	28,061
Dec 31, 2021	0
Sep 30, 2021	29,773
Jun 30, 2021	0
Mar 31, 2021	33,762
Dec 31, 2020	78,847
Sep 30, 2020	132,773
Jun 30, 2020	185,926
Mar 31, 2020	227,288
Dec 31, 2019	302,621
Sep 30, 2019	118,547,397
Jun 30, 2019	181,910
Dec 31, 2018	112,590,631